Retatrutide, from Soma Corp., is attracting significant attention as a innovative therapy for weight regulation. This innovative medication combines the activity of a GLP-1 receptor stimulant and a GIP receptor activator , designed to not only promote reduced body fat but also target related metabolic issues . Initial patient trials have shown impr